Liverpool Launches New Centre Of Excellence For Long-Acting Therapeutics

The University of Liverpool has launched a new research center for the development of revolutionary long-acting medicines that could transform the prevention and treatment of many diseases across the globe. Established as part of a £30.5 million ($40 million USD) international research consortium, primarily funded by Unitaid, the Centre of Excellence for Long-acting Therapeutics (CELT) will be the first of its kind in the world. CELT is co-directed by pharmacologist Professor Andrew Owen and materials chemist Professor Steve Rannard at the University of Liverpool.

By repurposing existing medicines into slow-release formulations, where drug effectiveness can . . .